Literature DB >> 25824300

Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.

M Hornig1,2, G Gottschalk3, D L Peterson3, K K Knox4,5, A F Schultz1, M L Eddy1, X Che1, W I Lipkin1,2,6.   

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome is an unexplained debilitating disorder that is frequently associated with cognitive and motor dysfunction. We analyzed cerebrospinal fluid from 32 cases, 40 subjects with multiple sclerosis and 19 normal subjects frequency-matched for age and sex using a 51-plex cytokine assay. Group-specific differences were found for the majority of analytes with an increase in cases of CCL11 (eotaxin), a chemokine involved in eosinophil recruitment. Network analysis revealed an inverse relationship between interleukin 1 receptor antagonist and colony-stimulating factor 1, colony-stimulating factor 2 and interleukin 17F, without effects on interleukin 1α or interleukin 1β, suggesting a disturbance in interleukin 1 signaling. Our results indicate a markedly disturbed immune signature in the cerebrospinal fluid of cases that is consistent with immune activation in the central nervous system, and a shift toward an allergic or T helper type-2 pattern associated with autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824300     DOI: 10.1038/mp.2015.29

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  48 in total

1.  Rac1 and Scribble are targets for the arrest of neurite outgrowth by TBE virus NS5.

Authors:  Michael Wigerius; Wessam Melik; Annelie Elväng; Magnus Johansson
Journal:  Mol Cell Neurosci       Date:  2010-04-02       Impact factor: 4.314

Review 2.  Is human herpesvirus-6 a trigger for chronic fatigue syndrome?

Authors:  Anthony L Komaroff
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

Review 3.  Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective.

Authors:  Leslie R Bisset; Peter Schmid-Grendelmeier
Journal:  Curr Opin Pulm Med       Date:  2005-01       Impact factor: 3.155

4.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

5.  Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge.

Authors:  David J Amrol; David D Hagaman; James R Sheller; John J Murray
Journal:  J Asthma       Date:  2005-02       Impact factor: 2.515

Review 6.  Role of infection and neurologic dysfunction in chronic fatigue syndrome.

Authors:  Anthony L Komaroff; Tracey A Cho
Journal:  Semin Neurol       Date:  2011-09-30       Impact factor: 3.420

7.  High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients.

Authors:  Jo Nijs; Garth L Nicolson; Pascale De Becker; Danny Coomans; Kenny De Meirleir
Journal:  FEMS Immunol Med Microbiol       Date:  2002-11-15

8.  Association between interleukin-1 receptor antagonist gene and asthma-related traits in a German adult population.

Authors:  C Pattaro; J Heinrich; M Werner; R de Marco; M Wjst
Journal:  Allergy       Date:  2006-02       Impact factor: 13.146

9.  Analysis of cerebrospinal fluid from chronic fatigue syndrome patients for multiple human ubiquitous viruses and xenotropic murine leukemia-related virus.

Authors:  Steven E Schutzer; Megan A Rounds; Benjamin H Natelson; David J Ecker; Mark W Eshoo
Journal:  Ann Neurol       Date:  2011-04-06       Impact factor: 10.422

10.  Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.

Authors:  A Martin Lerner; Maria E Ariza; Marshall Williams; Leonard Jason; Safedin Beqaj; James T Fitzgerald; Stanley Lemeshow; Ronald Glaser
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more
  36 in total

1.  Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.

Authors:  Paulo L Lizano; Matcheri S Keshavan; Neeraj Tandon; Ian T Mathew; Suraj Sarvode Mothi; Debra M Montrose; Jeffrey K Yao
Journal:  Schizophr Res       Date:  2015-12-11       Impact factor: 4.939

2.  Systematic model of peripheral inflammation after subarachnoid hemorrhage.

Authors:  Jude P J Savarraj; Kaushik Parsha; Georgene W Hergenroeder; Liang Zhu; Suhas S Bajgur; Sungho Ahn; Kiwon Lee; Tiffany Chang; Dong H Kim; Yin Liu; H Alex Choi
Journal:  Neurology       Date:  2017-03-17       Impact factor: 9.910

Review 3.  Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?

Authors:  Benjamin Heng; Gilles J Guillemin; Bahar Kavyani; Brett A Lidbury; Richard Schloeffel; Paul R Fisher; Daniel Missailidis; Sarah J Annesley; Mona Dehhaghi
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

4.  Metabolic features of chronic fatigue syndrome.

Authors:  Robert K Naviaux; Jane C Naviaux; Kefeng Li; A Taylor Bright; William A Alaynick; Lin Wang; Asha Baxter; Neil Nathan; Wayne Anderson; Eric Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

5.  Autonomic Nervous System Functioning Related to Nocturnal Sleep in Patients With Chronic Fatigue Syndrome Compared to Tired Controls.

Authors:  Maija Orjatsalo; Anniina Alakuijala; Markku Partinen
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

6.  Cytokine signature associated with disease severity in chronic fatigue syndrome patients.

Authors:  Jose G Montoya; Tyson H Holmes; Jill N Anderson; Holden T Maecker; Yael Rosenberg-Hasson; Ian J Valencia; Lily Chu; Jarred W Younger; Cristina M Tato; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

7.  B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.

Authors:  Øystein Fluge; Kristin Risa; Sigrid Lunde; Kine Alme; Ingrid Gurvin Rekeland; Dipak Sapkota; Einar Kleboe Kristoffersen; Kari Sørland; Ove Bruland; Olav Dahl; Olav Mella
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 8.  The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.

Authors:  Narges Moghimi; Mario Di Napoli; José Biller; James E Siegler; Rahul Shekhar; Louise D McCullough; Michelle S Harkins; Emily Hong; Danielle A Alaouieh; Gelsomina Mansueto; Afshin A Divani
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-28       Impact factor: 5.081

Review 9.  Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?

Authors:  Svetlana Blitshteyn
Journal:  J Neurol       Date:  2021-03-07       Impact factor: 4.849

10.  Immune markers are associated with cognitive performance in a multiethnic cohort: The Northern Manhattan Study.

Authors:  Mitchell S V Elkind; Michelle Moon; Tatjana Rundek; Clinton B Wright; Ken Cheung; Ralph L Sacco; Mady Hornig
Journal:  Brain Behav Immun       Date:  2021-07-25       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.